In-Hospital Complications of Acute Decompensated Heart Failure Patients With Comorbid Rheumatoid Arthritis: A Retrospective Cohort Study

Introduction Rheumatoid arthritis (RA) is associated with increased cardiovascular risk and chronic systemic inflammation, which may influence outcomes of heart failure (HF) hospitalization. However, the effect of RA on acute inpatient complications, bleeding risk, and mortality during HF admissions remains unclear. Methods We conducted a retrospective cohort study of adults hospitalized with HF across a large tertiary healthcare system from 2016 to 2024. The primary outcome was in-hospital mortality. Secondary outcomes included length of stay, gastrointestinal (GI) and major bleeding, pneumonia, respiratory failure, acute kidney injury (AKI), thromboembolism, and major adverse cardiac events (MACE). Multivariable logistic and negative binomial regression were used to assess associations after adjusting for demographics, comorbidities, laboratory values, and medications. Propensity score matching (PSM) minimized baseline confounding. Results The study included 81,366 HF patients. Those with RA were older, more often female, and had higher rates of chronic lung disease, systemic lupus erythematosus (SLE), and thrombocytopenia. After adjustment, RA was associated with higher odds of GI and major bleeding and longer hospital stays, but not with increased mortality or cardiovascular complications. Among those with RA, elevated C-reactive protein was associated with a higher risk of thromboembolic and cardiac complications. Pre-admission disease-modifying antirheumatic drug use was associated with lower thromboembolic risk, but higher risk of major adverse cardiac events. Conclusion RA was associated with a greater risk of bleeding complications and prolonged hospitalization during HF admissions but not increased in-hospital mortality. Elevated inflammatory markers and immunosuppressive therapy may contribute to thrombotic and cardiac complications and highlight the need for targeted monitoring strategies during hospitalization.

Authors

Publication Details

Journal
Cureus
Published
2026-07-26
DOI
https://doi.org/10.7759/cureus.113417
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In-Hospital Complications of Acute Decompensated Heart Failure Patients With Comorbid Rheumatoid Arthritis: A Retrospective Cohort Study

Javier Fernández, Javier Jimenez, Sandra Chaparro, Muni Rubens et al.
Cureus
Rheumatoid Arthritis Research and Therapies
article

In-Hospital Complications of Acute Decompensated Heart Failure Patients With Comorbid Rheumatoid Arthritis: A Retrospective Cohort Study

Javier Fernández, Javier Jimenez, Sandra Chaparro, Muni Rubens, Ning Sun, Anshul Saxena, Venkataraghavan Ramamoorthy
article en

Abstract

Introduction Rheumatoid arthritis (RA) is associated with increased cardiovascular risk and chronic systemic inflammation, which may influence outcomes of heart failure (HF) hospitalization. However, the effect of RA on acute inpatient complications, bleeding risk, and mortality during HF admissions remains unclear. Methods We conducted a retrospective cohort study of adults hospitalized with HF across a large tertiary healthcare system from 2016 to 2024. The primary outcome was in-hospital mortality. Secondary outcomes included length of stay, gastrointestinal (GI) and major bleeding, pneumonia, respiratory failure, acute kidney injury (AKI), thromboembolism, and major adverse cardiac events (MACE). Multivariable logistic and negative binomial regression were used to assess associations after adjusting for demographics, comorbidities, laboratory values, and medications. Propensity score matching (PSM) minimized baseline confounding. Results The study included 81,366 HF patients. Those with RA were older, more often female, and had higher rates of chronic lung disease, systemic lupus erythematosus (SLE), and thrombocytopenia. After adjustment, RA was associated with higher odds of GI and major bleeding and longer hospital stays, but not with increased mortality or cardiovascular complications. Among those with RA, elevated C-reactive protein was associated with a higher risk of thromboembolic and cardiac complications. Pre-admission disease-modifying antirheumatic drug use was associated with lower thromboembolic risk, but higher risk of major adverse cardiac events. Conclusion RA was associated with a greater risk of bleeding complications and prolonged hospitalization during HF admissions but not increased in-hospital mortality. Elevated inflammatory markers and immunosuppressive therapy may contribute to thrombotic and cardiac complications and highlight the need for targeted monitoring strategies during hospitalization.

Cureus
Good health and well-being
Openalex Percentile: Top 8%
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.